93 related articles for article (PubMed ID: 21697059)
1. Peroxisome proliferator receptor (PPAR) β/δ in psoriatic patients before and after two conventional therapeutic modalities: methotrexate and PUVA.
El Eishi N; Hegazy R; Abou Zeid O; Shaker O
Eur J Dermatol; 2011; 21(5):691-5. PubMed ID: 21697059
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic effect of methotrexate and PUVA on psoriasis.
Shaker OG; Khairallah M; Rasheed HM; Abdel-Halim MR; Abuzeid OM; El Tawdi AM; El Hadidi HH; Ashmaui A
Cell Biochem Biophys; 2013 Nov; 67(2):735-42. PubMed ID: 23504632
[TBL] [Abstract][Full Text] [Related]
3. Connexin 26 in psoriatic skin before and after two conventional therapeutic modalities: methotrexate and PUVA.
Shaker O; Abdel-Halim M
Eur J Dermatol; 2012; 22(2):218-24. PubMed ID: 22361809
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 in psoriatic plaques treated with PUVA and methotrexate.
El-Komy M; Amin I; Zidan A; Kadry D; Zeid OA; Shaker O
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1288-94. PubMed ID: 21241374
[TBL] [Abstract][Full Text] [Related]
5. Estimation of tissue osteopontin levels before and after different traditional therapeutic modalities in psoriatic patients.
El-Eishi NH; Kadry D; Hegazy RA; Rashed L
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):351-5. PubMed ID: 22221192
[TBL] [Abstract][Full Text] [Related]
6. [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?].
Wollina U; Schulze M; Schaarschmidt H; Barta U; Pfeiffer L; Knopf B; Horn A
Z Hautkr; 1985 Mar; 60(6):527-30. PubMed ID: 2581382
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha 2-macroglobulin levels in psoriatic patients treated with UVB and PUVA.
Gasior-Chrzan B; Dotterud LK; Falk ES
Riv Eur Sci Med Farmacol; 1996; 18(3):125-8. PubMed ID: 9177609
[TBL] [Abstract][Full Text] [Related]
9. Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis.
Mössner R; Kaiser R; Matern P; Krüger U; Westphal GA; Brockmöller J; Ziegler A; Neumann C; König IR; Reich K
Arch Dermatol Res; 2004 Jun; 296(1):1-5. PubMed ID: 15083308
[TBL] [Abstract][Full Text] [Related]
10. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
[TBL] [Abstract][Full Text] [Related]
11. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
12. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis.
Shehzad T; Dar NR; Zakria M
J Pak Med Assoc; 2004 Sep; 54(9):453-5. PubMed ID: 15518366
[TBL] [Abstract][Full Text] [Related]
15. [Photochemotherapy for psoriatic patients treated with corticosteroids and methotrexate].
Gschnait F; Konrad K; Hönigsmann H; Wolff K
Hautarzt; 1977 Dec; 28(12):632-7. PubMed ID: 599023
[TBL] [Abstract][Full Text] [Related]
16. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
17. Expression of peroxisome proliferator activator receptor β/δ (PPARβ/δ) in acne vulgaris.
Elmongy NN; Shaker O
Eur J Dermatol; 2012; 22(1):42-5. PubMed ID: 22146481
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activated receptor beta/delta activation prevents extracellular regulated kinase 1/2 phosphorylation and protects the testis from ischemia and reperfusion injury.
Minutoli L; Antonuccio P; Polito F; Bitto A; Squadrito F; Irrera N; Nicotina PA; Fazzari C; Montalto AS; Di Stefano V; Romeo C; Altavilla D
J Urol; 2009 Apr; 181(4):1913-21. PubMed ID: 19237170
[TBL] [Abstract][Full Text] [Related]
19. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
Kane D; Gogarty M; O'leary J; Silva I; Bermingham N; Bresnihan B; Fitzgerald O
Arthritis Rheum; 2004 Oct; 50(10):3286-95. PubMed ID: 15476228
[TBL] [Abstract][Full Text] [Related]
20. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
Mom A; Aresca S; Fuente G; Pecorini V; Pellerano G; Perez V
Acta Derm Venereol; 1982; 62(4):357-8. PubMed ID: 6183878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
